about
Personalization of the immunosuppressive treatment in renal transplant recipients: the great challenge in "omics" medicineMechanism of accommodation in a sensitized human leukocyte antigen transgenic murine cardiac transplant modelDiagnosis of c4d+ renal allograft acute humoral rejection by urine protein fingerprint analysis.Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts.Systemic meta-analysis assessing the short term applicability of early conversion to mammalian target of rapamycin inhibitors in kidney transplant.Molecular mechanisms of chronic kidney transplant rejection via large-scale proteogenomic analysis of tissue biopsies.Urinary proteomic analysis of chronic allograft nephropathy.Detection of renal allograft dysfunction with characteristic protein fingerprint by serum proteomic analysis.Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers.Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice.Excretion of anti-angiogenic proteins in patients with chronic allograft dysfunction.Serum HSP27 is associated with medullary perfusion in kidney allograftsNox-2 is a modulator of fibrogenesis in kidney allograftsEarly epithelial phenotypic changes predict graft fibrosis.Oxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allografts.HSP27 is involved in the pathogenesis of kidney tubulointerstitial fibrosis"Nature versus nurture" study of deceased-donor pairs in kidney transplantation.Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis.Prevalence and risk factors for early chronic allograft nephropathy in a live related renal transplant programRole of Toll-like receptors in transplantation tolerance.Biological pathways and potential targets for prevention and therapy of chronic allograft nephropathyIs Early Conversion to mTOR Inhibitors Represent a Suitable Choice in Renal Transplant Recipients? A Systemic Review of Medium-term OutcomesAcute rejection features in dual kidney transplant recipients from elderly donors: comparison of calcineurin inhibitor-based and calcineurin inhibitor-free immunosuppressive protocols.Pargyline reduces renal damage associated with ischaemia-reperfusion and cyclosporin
P2860
Q28082746-5DBF4D7B-42B0-4C61-8069-F601FA9C827DQ30422315-C2F42346-5121-4689-8933-259BD8351202Q33541351-4CE2C885-12AA-49ED-852E-49AB9B5306C5Q33561691-C85A6057-CC68-40F3-A1C7-65BBEC1838A1Q33617408-2DA554F7-3302-4136-BD34-5309832E9595Q33711255-8EC7C7D7-D910-404E-A718-0B722C534332Q33764407-6D41053F-9E2E-4135-A25F-5004F043D220Q33880906-9D1FDB87-3208-4450-A0D0-F8413208D3AFQ34342506-D7FF89A3-F287-4781-A7C6-B0389EB32685Q35655757-FE809F78-ECB6-4878-8F02-18EAE96506D8Q35745748-22CCD910-81F8-4DEF-9ED7-44AB0567A5EEQ36172279-3CC3758E-247B-4E34-A9ED-B1A0F48C8D97Q36611193-94845803-DB49-4F9A-B044-B9CB43E93E9BQ36796755-DAF58EFA-44DD-427D-9152-23DDDC2D6844Q36802004-DF4B9EF1-607B-4166-BB39-73731755D226Q36877844-D31287A8-2D9A-43AF-BEA9-A6499F427D0EQ37211099-D5AB9D32-B6BB-45D5-A376-28E8E9949A1CQ37218081-00892580-B8C0-48A4-8D27-E03CB5B27128Q37723175-B91D43FD-20E0-422A-B77B-F3B93BA2BDE7Q37754767-C4846722-6E49-461E-B2DE-B3338BA7923FQ38223778-DFBF1803-2EE2-4C24-ADC4-F82E94D7B9C9Q41313340-CFB7F919-0B21-4410-8962-53097E71CD10Q43194453-260A76E4-A9D1-4494-81AC-336B951E2E81Q57718639-FD6498C2-E8D0-489B-83F3-D1E634A3A6EE
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Chronic allograft nephropathy.
@ast
Chronic allograft nephropathy.
@en
type
label
Chronic allograft nephropathy.
@ast
Chronic allograft nephropathy.
@en
prefLabel
Chronic allograft nephropathy.
@ast
Chronic allograft nephropathy.
@en
P1476
Chronic allograft nephropathy.
@en
P2093
Lynn D Cornell
Robert B Colvin
P304
P356
10.1097/01.MNH.0000165888.83125.07
P577
2005-05-01T00:00:00Z